We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric Hospital.
- Authors
Brothers, Adam W; Pak, Daniel J; Poole, Nicole M; Kronman, Matthew P; Bettinger, Brendan; Wilkes, Jennifer J; Carpenter, Paul A; Englund, Janet A; Weissman, Scott J
- Abstract
Background Providers must balance effective empiric therapy against toxicity risks and collateral damage when selecting antibiotic therapy for patients receiving hematopoietic cell transplant (HCT). Antimicrobial stewardship interventions during HCT are often challenging due to concern for undertreating potential infections. Methods In an effort to decrease unnecessary carbapenem exposure for patients undergoing HCT at our pediatric center, we implemented individualized antibiotic plans (IAPs) to provide recommendations for preengraftment neutropenia prophylaxis, empiric treatment of febrile neutropenia, and empiric treatment for hemodynamic instability. We compared monthly antibiotic days of therapy (DOT) adjusted per 1000 patient-days for carbapenems, antipseudomonal cephalosporins, and all antibiotics during two 3-year periods immediately before and after the implementation of IAPs to measure the impact of IAP on prescribing behavior. Bloodstream infection (BSIs) and Clostridioides difficile (CD) positivity test rates were also compared between cohorts. Last, providers were surveyed to assess their experience of using IAPs in antibiotic decision making. Results Overall antibiotic use decreased after the implementation of IAPs (monthly reduction of 19.6 DOT/1000 patient-days; P =.004), with carbapenems showing a continuing decline after IAP implementation. BSI and CD positivity rates were unchanged. More than 90% of providers found IAPs to be either extremely or very valuable for their practice. Conclusions Implementation of IAPs in this high-risk HCT population led to reduction in overall antibiotic use without increase in rate of BSI or CD test positivity. The program was well received by providers.
- Subjects
ANTIMICROBIAL stewardship; FEBRILE neutropenia; CHILDREN'S hospitals; INDIVIDUALIZED medicine; ANTIBIOTIC prophylaxis; CEPHALOSPORINS; QUALITY assurance; PATHOGENIC microorganisms; DESCRIPTIVE statistics; CARBAPENEMS; HEMATOPOIETIC stem cell transplantation; HEMODYNAMICS; DECISION making in clinical medicine; ANTIBIOTICS; BLOODBORNE infections; LONGITUDINAL method
- Publication
Clinical Infectious Diseases, 2024, Vol 78, Issue 1, p15
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciad518